Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

Lumonus, an AI-native oncology workflow platform company, closed a A$25 million Series B led by Aviron Investment Management with continued participation from Oncology Ventures. The funding will expand U.S. go‑to‑market and clinical success teams and advance its products (AI Physician and AI Dosimetry). Lumonus reports its platform has supported clinicians in consulting/prescribing over 280,000 cancer treatments and automated creation of 75,000+ treatment plans across the U.S., Australia, and Europe.